Hers Skincare Alternatives: The Best Options for Every Use Case

Is Hers Skincare Legit? A Critical Look

Hers Skincare is a legitimate, licensed telehealth platform that connects women to licensed providers who can prescribe topical medications. The prescriptions are real. The pharmacy fulfillment is through licensed compounding pharmacies. "legit" and "best for you" are two separate questions.

Hers launched as part of the broader Hims and Hers Health platform and markets heavily to women in their 20s and 30s seeking acne or anti-aging care. The business model is subscription D2C: you fill out a photo intake form, a provider reviews it asynchronously, and a customized compounded formula arrives by mail.

What Hers Actually Prescribes

The core Hers skincare formulas typically combine two to four active ingredients in a single pump or cream:

• Tretinoin (0.025% to 0.1%) for cell turnover, acne, and fine lines
• Azelaic acid (15% or 20%) for pigmentation and redness
• Niacinamide (4% to 10%) to reduce pore appearance and post-inflammatory hyperpigmentation
• Clindamycin (1%) for inflammatory acne
• Hydroquinone (2% to 4%) for melasma and dark spots

These are clinically meaningful ingredients. Tretinoin remains the most evidence-backed topical retinoid for acne and photoaging, with decades of randomized trial data. Azelaic acid has strong evidence for papulopustular rosacea and post-inflammatory hyperpigmentation in women with darker skin tones.

Where Hers Falls Short

The complaints in independent reviews cluster around three areas. First, ingredient transparency: Hers does not always disclose exact concentrations until after sign-up. Second, formula inflexibility: the multi-ingredient compounded approach means you cannot easily isolate which ingredient is causing irritation. Third, provider access: asynchronous-only consults mean no real-time conversation when a reaction occurs.

For women with complex skin histories (autoimmune skin conditions, hormone-driven melasma, perimenopausal skin changes), a single asynchronous intake rarely captures enough nuance.

Who Hers Skincare Is Right For, And Who Should Look Elsewhere

The right platform depends on your skin goal, life stage, and how much clinical oversight you want.

Women Who Tend to Do Well with Hers

• Reproductive-age women (roughly 20 to 39) with mild-to-moderate comedonal or inflammatory acne and no major complicating conditions
• Women who want a set-and-forget monthly subscription and are not planning pregnancy in the near term (see the pregnancy section below)
• First-time tretinoin users who prefer a lower starting concentration blended with a moisturizing base to reduce initial peeling

Women Who Should Consider an Alternative First

• Trying to conceive or pregnant: Tretinoin is FDA Pregnancy Category X. The Hers intake form does ask about pregnancy intent, and responsible providers should not prescribe tretinoin here, but the asynchronous model adds risk. More on this in the dedicated section below.
• Perimenopausal or postmenopausal women whose skin changes (thinning, dryness, loss of elasticity) are driven largely by estrogen decline. Topical actives help, but addressing the root hormonal cause through a menopause-informed provider often matters more.
• Women with melasma worsened by hormonal contraception or pregnancy: Melasma management requires a nuanced discussion of sun protection, hydroquinone cycling, and potential hormonal contributions that a photo-intake form may not capture adequately.
• Women with PCOS-related hyperandrogenic acne: The androgen excess driving cystic jawline and chin acne in PCOS responds better to systemic hormonal therapy (combined OCP or spironolactone) than to topical tretinoin alone. A platform that can prescribe both topical and systemic options is a better fit.

The Best Hers Skincare Alternatives by Use Case

No single competitor is best across every goal. Below, each alternative is matched to a specific clinical need with honest trade-offs.

For Tretinoin + Anti-Aging: Curology or Apostrophe

Curology offers a similar photo-intake model but publishes exact concentrations on the label and allows asynchronous messaging with providers between formulas. Monthly pricing starts around $29, $39 for the base plan, making it meaningfully cheaper than Hers for straightforward tretinoin prescriptions.

Apostrophe uses synchronous video visits for the initial consult, which is clinically superior for complex presentations. Providers there can also prescribe oral medications (spironolactone, antibiotics) alongside topicals, giving a broader toolkit. A 2021 review in JAMA Dermatology found that teledermatology platforms providing photo-based consultation achieved diagnostic accuracy comparable to in-person visits for acne when structured intake was adequate, though this was not specific to any one brand.

For Hormonal Acne in Reproductive Years: Platforms Offering Spironolactone

Hormonal acne in women, especially the deep cystic breakouts along the jawline and lower face, is driven by androgen activity. Spironolactone 50 to 200 mg/day significantly reduces sebum production and inflammatory lesions in women with hormonal acne. Hers does not prescribe spironolactone (an oral medication) as part of its skincare program. Platforms that do include:

• Apostrophe (oral prescriptions available)
• Keeps / Hims for Women equivalent (limited formulary)
• Your OB-GYN or a women's-health NP via your existing telehealth plan, who can also co-manage your contraception (spironolactone requires reliable contraception due to teratogenic risk in male fetuses)

If you have PCOS and acne, getting both conditions addressed through a single provider familiar with PCOS management guidelines from the ASRM is more efficient than patching together separate telehealth subscriptions.

For Melasma: Musely or an In-Person Derm

Musely specializes in compounded formulas for hyperpigmentation and melasma, with a dedicated intake that asks about oral contraceptive use, pregnancy history, and sun exposure patterns, all relevant melasma triggers in women. Their formulas can include tretinoin, hydroquinone, kojic acid, and corticosteroids in combination, a regimen supported by evidence from the American Academy of Dermatology guidelines on melasma management.

For women whose melasma worsened during pregnancy or on estrogen-containing contraceptives, the first intervention is discontinuing or switching the hormonal trigger, a conversation that benefits from an OB-GYN or reproductive endocrinologist, not just a skincare telehealth app.

For Perimenopausal and Postmenopausal Skin: Address the Hormonal Root Cause

Skin during perimenopause and after menopause thins, loses collagen, and becomes drier as estrogen falls. Estrogen receptors are abundant in skin; estrogen promotes collagen synthesis, sebum production, and wound healing. Prescription topicals (tretinoin, peptides) can partially compensate, but they do not replace systemic estrogen's structural effects.

Women in this life stage get more mileage from a clinician who can discuss menopausal hormone therapy (MHT) alongside a topical regimen. The Menopause Society (formerly NAMS) position statement notes that systemic MHT improves skin collagen content and thickness in postmenopausal women, a benefit topical retinoids cannot replicate alone.

For topical support in this group, a compounding pharmacy (via an in-person derm or menopause-certified clinician) can formulate topical estradiol or topical estriol face creams, though these are off-label for skin indications and the evidence base is preliminary.

For Rosacea: Derrow or a Board-Certified Dermatologist

Rosacea affects roughly 16 million American women, peaks in perimenopause, and is often worsened by tretinoin at standard concentrations. Hers' primary formula, which frequently includes tretinoin, may not be appropriate for women with rosacea-dominant presentations. Derrow is a telehealth platform that focuses on dermatology-specific diagnoses; their providers are board-certified dermatologists, not general practitioners, and can prescribe metronidazole 0.75 to 1%, ivermectin 1% cream (Soolantra), and azelaic acid 15% gel, the first-line topicals in the American Academy of Dermatology rosacea guidelines.

For Budget-First OTC Options: The Science-Backed Stack

Not every skin goal requires a prescription. For women who want evidence-based care without a subscription:

| Goal | OTC Ingredient | Evidence Level | |---|---|---| | Anti-aging / texture | Retinol 0.3 to 1% (adapalene 0.1% OTC) | Strong: RCT data | | Hyperpigmentation | Vitamin C (L-ascorbic acid 10 to 20%) + SPF 50 | Moderate | | Acne | Adapalene 0.1% gel (Differin) | Strong: FDA-cleared | | Redness / PIH | Niacinamide 5 to 10% | Moderate | | Melasma maintenance | Tranexamic acid 3 to 5% + strict SPF | Moderate |

Adapalene 0.1% gel was approved OTC by the FDA and reduces both inflammatory and non-inflammatory acne lesions by approximately 50% at 12 weeks in RCTs. It is not equivalent to tretinoin 0.05 to 0.1% for anti-aging, but it costs $12, $18 per tube and requires no consult fee.

Pregnancy, Lactation, and Contraception: The Non-Negotiable Section

This section applies to any woman using or considering prescription skincare at any life stage. The risks are real and under-discussed in D2C brand marketing.

Tretinoin: Contraindicated in Pregnancy

Tretinoin (all-trans retinoic acid) is FDA Pregnancy Category X. Oral retinoids (isotretinoin) cause major birth defects in 20 to 35% of first-trimester exposures; topical tretinoin has far lower systemic absorption, but the FDA label is unambiguous: do not use during pregnancy. The teratogenic mechanism, disruption of retinoic acid receptor signaling during embryogenesis, does not have a safe threshold established in human data.

Contraception requirement: Any woman of reproductive age prescribed tretinoin by any platform (Hers, Curology, Apostrophe, or otherwise) should use reliable contraception. If you are trying to conceive, stop tretinoin and wait at least one menstrual cycle before attempting pregnancy. Discuss timing with your OB-GYN.

Lactation: Topical tretinoin has minimal systemic absorption, and the LactMed database classifies maternal topical tretinoin use as unlikely to pose risk to a nursing infant, but the data are sparse. Avoid applying it to breast skin if nursing.

Hydroquinone: Avoid in Pregnancy and Lactation

Systemic absorption of hydroquinone through skin is measurable. The FDA proposed reclassifying hydroquinone from Category C to not generally recognized as safe and effective (NGRASE) in 2006, citing carcinogenicity data in animal studies. Most dermatologists advise stopping hydroquinone-containing formulas when trying to conceive or during pregnancy. Alternatives for hyperpigmentation in pregnancy include topical vitamin C, azelaic acid, and strict SPF.

Azelaic Acid: Generally Compatible with Pregnancy

Azelaic acid 15 to 20% is FDA Pregnancy Category B, meaning no evidence of fetal risk in animal studies and no adequate human studies showing risk. It is widely used by dermatologists as a safe option for acne and rosacea in pregnant women. This is one area where Hers' formula containing azelaic acid may be appropriate to continue in pregnancy, but always confirm with your OB-GYN before continuing any prescription product.

Clindamycin 1% Topical: Low Risk in Pregnancy

Topical clindamycin is considered safe in pregnancy for acne treatment per ACOG guidance on dermatologic conditions in pregnancy. Systemic absorption is minimal. It is a reasonable option when tretinoin must be stopped.

Niacinamide: Compatible with Pregnancy and Lactation

Niacinamide (vitamin B3) at 4 to 10% is considered safe throughout pregnancy and lactation. No known teratogenic risk exists at topical doses.

Life-stage summary for prescription skincare:

| Life Stage | Tretinoin | Hydroquinone | Azelaic Acid | Clindamycin (topical) | |---|---|---|---|---| | Reproductive (not TTC) | Yes, with contraception | Use with caution | Yes | Yes | | Trying to conceive | Stop, wait 1 cycle | Stop | Yes | Yes | | Pregnant | No (Category X) | Avoid | Yes (Cat B) | Yes | | Breastfeeding | Caution, avoid breast skin | Avoid | Yes | Yes | | Perimenopausal / Postmenopausal | Yes | Yes (with cycling) | Yes | Yes |

How Much Does Hers Skincare Cost, and How Do Alternatives Compare?

Hers pricing is structured around a subscription model. The initial provider consultation runs $25, $49. The monthly formula subscription is typically $49, $89 depending on the active ingredients included. Annual spend lands around $648, $1,188 for consistent users.

Competitors by price tier:

| Platform | Consult Cost | Monthly Formula | Prescription Oral Meds? | Synchronous Visit? | |---|---|---|---|---| | Hers | $25, $49 | $49, $89 | No (topical only) | No (async) | | Curology | $0 (free trial) | $29, $39 | No | No (async) | | Apostrophe | $20 | $40, $75 | Yes (spiro, antibiotics) | Yes (video) | | Musely | $20, $30 | $49, $79 | No | No (async) | | Derrow | $75, $150 | Varies | Yes | Yes (video) | | In-person derm | $150, $350 | Varies | Yes | Yes |

The "free trial" caveat on Curology: the trial period (30 days) converts to a paid subscription automatically. Set a calendar reminder if you want to assess before committing.

Sex-Specific Physiology: Why Your Skin Changes Across the Menstrual Cycle

Skin is not static across your cycle, and no D2C skincare brand's intake form currently asks about this.

During the follicular phase (days 1 to 14), rising estrogen thickens skin slightly and increases hydration. Sebum production is relatively low. Skin typically tolerates active ingredients well in this window.

Around ovulation and into the luteal phase (days 15 to 28), progesterone rises and stimulates sebaceous gland activity. Sebum secretion is significantly higher in the luteal phase, correlating with acne flare frequency in women with hormonal acne. If you notice that tretinoin or azelaic acid causes more irritation in the week before your period, this is a physiological pattern, not product failure. Adjusting application frequency (every other night in the late luteal phase) is a practical clinical strategy rarely discussed in D2C brand FAQs.

Perimenopause adds another variable: irregular cycles mean unpredictable hormonal shifts, and falling estrogen reduces skin barrier function, making tretinoin-induced irritation more likely at concentrations that felt fine at 30. Starting at 0.025% and titrating slowly matters more in this life stage.

Is Hers Skincare Worth It? An Honest Assessment

For a 28-year-old woman with mild comedonal acne, no pregnancy plans in the near term, and no history of rosacea or complex hyperpigmentation, Hers offers a real tretinoin prescription at a reasonable price with zero in-office wait time. That is a legitimate value.

For most other use cases, though, a competitor does the job better:

• Curology for lower cost with similar async convenience
• Apostrophe for anyone who also needs oral medications
• Musely for melasma-specific formulas
• Derrow for rosacea or complex inflammatory presentations
• Your OB-GYN or menopause clinician for perimenopausal skin where hormones are the primary driver

The honest evidence gap: no published randomized controlled trial compares compounded telehealth formulas from competing D2C brands. The ingredient evidence exists for tretinoin, azelaic acid, and niacinamide individually. Whether Hers' specific combinations outperform Curology's at matched concentrations is simply unknown. Any brand claiming superiority on "formula blending" is marketing, not science.

As WomanRx clinician reviewer Elena Vasquez, MD, notes: "The platform matters less than who's reviewing your intake and whether they can prescribe the full toolkit your skin needs at your specific life stage. Topical tretinoin alone won't touch cystic hormonal acne in a 42-year-old in perimenopause the same way it works in a 25-year-old with sebaceous skin."

Practical Next Steps Based on Your Situation

If you are currently using Hers and it is working, there is no clinical reason to switch. Check your formula label for exact concentrations, use SPF 30 or higher every morning (tretinoin increases photosensitivity), and if you are starting to think about pregnancy, contact your provider before your next cycle to discuss stopping tretinoin and transitioning to pregnancy-safe alternatives.

If Hers is not working, map your unmet need to the alternative above. Hormonal acne needs systemic treatment. Perimenopausal skin needs a menopause-literate clinician. Melasma needs trigger identification first, topicals second.

The single most cost-effective step for any woman using prescription actives: SPF 50, daily, year-round. Consistent daily SPF use reduces photoaging progression more than any topical prescription in long-term cohort data. No subscription required.